405. Hindlimb and Forelimb Strength Assessment in a Canine Model of X-Linked Myotubular Myopathy Following AAV-Mediated Gene Replacement Molecular.

Slides:

Advertisements

Similar presentations

Gene Preference in Maple Syrup Urine Disease Mary M. Nellis, Dean J. Danner The American Journal of Human Genetics Volume 68, Issue 1, Pages (January.

Advertisements

Jennifer G. Cheung, Krystyna Konopka, Nejat Düzgünes

Volume 20, Issue 2, (February 2012)

414. A Novel Clinical Severity Scoring Measure in Canine X-Linked Myotubular Myopathy: Results Following Systemic AAV Gene Replacement Molecular Therapy

209. Use of Helicobacter pyroli Neutrophil Activating Protein (NAP) as an Immune- Modulatory Agent To Enhance the Efficacy of Oncolytic Adenovirus Therapy.

446. Gender Differences in the Osteogenic & Chondrogenic Potential of Human Muscle- Derived Stem Cells In Vitro Alex C. Scibetta, Andrea B. Liebowitz,

Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human Cancers Melinda Mata, Stephen.

Engineering Natural Killer Cells for Cancer Immunotherapy

Genome-editing Technologies for Gene and Cell Therapy

How to Treat MDS without Stem Cell Transplantation

627. Non-Invasive, Multimodal Imaging of Microvesicles with Metabolically Biotinylated, Membrane-Bound Gaussia Luciferase Molecular Therapy Volume.

Elizabeth Morris, Alex Scibetta, Aiping Lu, Xueqin Gao, Johnny Huard

162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo

281. Rapid Generation of Induced Pluripotent Stem Cells (iPSCs) from the Urine of a Patient with Duchenne Muscular Dystrophy Molecular Therapy Volume.

Direct Conversion of Skin Cells into Blood: Alchemy or Science?

Molecular Therapy Volume 20, Pages S261-S262 (May 2012) DOI: /S (16)

Evolving Gene Therapy in Primary Immunodeficiency

343. Benchtop DNA Synthesizer: Oligo-Templated Polymerization (OTP)

FIX It in One Go: Enhanced Factor IX Gene Therapy for Hemophilia B

Section 5: Dialysis Interventions for Treatment of AKI

Engineering Natural Killer Cells for Cancer Immunotherapy

637. Effect of PEG Grafting Degree on Morphology and Transfection Efficiency of Polycation-g-PEG/DNA Nanoparticles Molecular Therapy Volume 20, (May.

Escaping the Valley of Death

220. AAV-Mediated miR122 Overexpression Rescues Hepatic Inflammatory Response Induced by Acute Iron-Overload Min Li, Yuxiao Tang, Lusha Wu, Fengfeng.

Francesco Paolo Schena Kidney International

498. Prolonged Benefit from Systemic rAAV8 in a Canine Model of Myotubular Myopathy Matthew Elverman, David Mack, Melissa Goddard, Jessica Snyder, Robert.

John R. Martin, Christopher E. Nelson, Mukesh K

Volume 26, Issue 2, Pages (February 2018)

Volume 25, Issue 1, Pages 5-7 (January 2017)

Chen Ling, Baozheng Li, Wenqin Ma, George Aslanidi, Arun Srivastava

The Other Face of Chimeric Antigen Receptors

Follicular Lymphoma: Prognostic Factors, Conventional Therapies, and Hematopoietic Cell Transplantation Laurie H. Sehn, Timothy S. Fenske, Ginna G. Laport

724. Blood-Derived Endothelial Progenitor Cells Can Be Isolated With a Novel Method of Diluted Whole Blood Incubation with AMD3100-Induced Mobilization.

Genome-editing Technologies for Gene and Cell Therapy

Premal Lulla, Carlos A. Ramos Molecular Therapy

Molecular Therapy Volume 20, (May 2012) DOI: /S (16)

Molecular Therapy Volume 7, Issue 5, (May 2003) DOI: /S (16)

547. AAV Preparations Contain Contamination from DNA Sequences in Production Plasmids Directly Outside of the ITRs Mark A. Brimble, Junfang Zhou, Christopher.

847. Eradication of Therapy-Resistant Human Prostate Tumors Using an Ultrasound Guided Site-Specific Cancer Terminator Virus Delivery Approach Molecular.

611. Alpha-Dystrobrevin-3 Prevents Myopathy and Restores Diaphragm Function in the Alpha-Dystrobrevin Null Mouse Guy L. Odom, Glen B. Banks, Marvin E.

Designer Lipids Advance Systemic siRNA Delivery

133. Survival with Normal Neurological Development of the Juvenile Lethal Urea Cycle Defect Arginase Deficient Mouse with AAV Gene Therapy Molecular.

660. Bowel/Bladder Sensation and Control in Patients with Spinal Cord Injury Treated with Human Embryonic Stem Cell Therapy Geeta Shroff Molecular Therapy

Volume 26, Issue 2, Pages (February 2018)

68. Site Specific Intra-Placental Gene Transfer Corrects Fetal Growth Restriction in a Novel Mouse Model of Placental Insufficiency (PI) Molecular.

521. Multiplex Genome Editing of TCR°/CD52 Genes as a Platform for “Off the Shelf” Adoptive T-Cell Immunotherapies Molecular Therapy Volume 22, Pages.

Jennifer G. Cheung, Krystyna Konopka, Nejat Düzgünes

Chae-lyul Limg, Yeon-Ju Lee, Sujeong Kim

335. High Content Analysis Platform for Optimization of Lipid Mediated CRISPR-Cas9 Delivery Strategies in Human Cells Benjamin Steyer, Jared Carlson-Stevermer,

Volume 26, Issue 4, Pages (April 2018)

Gerard Socié, K. Scott Baker, Smita Bhatia

674. Molecular, Biochemical and Biomechanical Analysis of Articular Cartilage Repaired with Genetically Modified Chondrocytes Expressing Insulin-Like.

Molecular Therapy Volume 18, Pages S260-S261 (May 2010) DOI: /S (16)

In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)

372. Targeted Mutagenesis of Ubiquitin-Binding Lysine Residues on the Adeno- Associated Virus (AAV)2 Capsid Improves Its Transduction Efficiency Molecular.

521. AAV Immunotherapy Induces Functional Antigen Specific Regulatory T-Cells to a Neuroantigen: A Potential Treatment for MS Brad E. Hoffman Molecular.

483. In Vivo DMD Gene Editing in Muscles and Muscle Stem Cells of Dystrophic Mice Mohammadsharif Tabebordbar, Kexian Zhu, Jason Cheng, Jeffrey Widrick,

773. Detection of RNA Interference (RNAi) Mediated mRNA Cleavage in Fresh Injected Tumor Tissue from Patients in a Phase I Trial of pbi-shRNA™ Lipoplex.

740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells Molecular Therapy Volume 20, Pages S285-S286.

Molecular Therapy Volume 21, Pages S247-S248 (May 2013)

Shigeki Yagyu, Malcolm K. Brenner

History of Oncolytic Viruses: Genesis to Genetic Engineering

86. A Highly Compact Epitope-Based Marker Suicide Gene for Safer and Easier Adoptive T-Cell Gene Therapy Molecular Therapy Volume 20, Pages S35-S36.

297. Minimally Invasive Implantation of Autologous Chondrocytes Transduced with rAAV5-IGF-I Improves Longterm Cartilage Repair in Full-Thickness Chondral.

441. Direct Comparison of EF1α and PGK Promoters Reveals Superior Performance of the PGK Promoter for Expression of the Common Gamma Chain in a Canine.

10. High-Efficiency Transduction of Primary Human CD34+ Hematopoietic Stem/Progenitor Cells by AAV6 Serotype Vectors: Strategies for Overcoming Donor.

Sensing Bad: Are Co-stimulatory CAR-Expressing γδ T Cells Safer?

Jingxian Feng, Jiawen Wang, Junsheng Lin, Yong Diao

Shirley Wong, Roderick A. Slavcev

624. Randomized Phase II Trial of Adjuvant Autologous Tumor Cell Vaccine (FANG™) for High Risk Stage III/IV Ovarian Cancer: Preliminary Results Molecular.

Presentation transcript:

405. Hindlimb and Forelimb Strength Assessment in a Canine Model of X-Linked Myotubular Myopathy Following AAV-Mediated Gene Replacement Molecular Therapy Volume 22, Pages S154-S155 (May 2014) DOI: 10.1016/S1525-0016(16)35418-1 Copyright © 2014 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 a) Comparison of all forelimb extension torque measurements to hindlimb flexion torque measurements. b) Comparison of forelimb extension torque measurements to hindlimb flexion torque measurements separated by treatment group. Molecular Therapy 2014 22, S154-S155DOI: (10.1016/S1525-0016(16)35418-1) Copyright © 2014 The American Society of Gene & Cell Therapy Terms and Conditions